Comparison of the prevalence of alcohol, cannabis and other drugs between 900 injured drivers and 900 control subjects: results of a French collaborative study

Huestis, 2002, Cannabis (marijuana): effects on human behavior and performance, Forensic Sci. Rev., 14, 15

Kurzthaler, 1999, Effect of cannabis use on cognitive functions and driving ability, J. Clin. Psychiatr., 60, 395, 10.4088/JCP.v60n0609

Fant, 1998, Acute and residual effects of marijuana in humans, Pharmacol. Biochem. Behav., 60, 777, 10.1016/S0091-3057(97)00386-9

Drummer, 2002, Benzodiazepines: effects on human and behavior, Forensic Sci. Rev., 14, 1

Barnett, 1985, Behavioral pharmacokinetics of marijuana, Psychopharmacology, 85, 51, 10.1007/BF00427321

Linnoila, 1973, Interaction of alcohol and drugs on psychomotor skills as demonstrated by a driving simulator, Br. J. Pharmacol., 47, 671

Attwood, 1980, Effects of moderate blood alcohol concentrations on closed-course driving performance, J. Stud. Alcohol, 41, 623, 10.15288/jsa.1980.41.623

P. Kintz, N. Samyn, A. Verstraete, Les prélèvements biologiques et techniques analytiques. In: P. Mura (Eds.), Alcool, Médicaments, Stupéfiants et Conduite Automobile, ISBN 2-84299-136-2, Elsevier, Paris, 1999, pp. 143–169.

Deveaux, 1991, Alcool et médicaments psychotropes dans les accidents mortels de la circulation, Sem. Hôp. Paris, 67, 1372

Mura, 1999, Place des accidents dans les accidents mortels et corporels en France: résultats de 169 analyses réalisées en 1998 et 1999 à la demande d’une autorité judiciaire, Toxicorama, 11, 225

Kintz, 2000, Analyses toxicologiques pratiquées sur 198 conducteurs accidentés, Presse Med., 29, 1275

Longo, 2000, The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability. Part II. The relationship between drug prevalence and drug concentration, and driver culpability, Accid. Anal. Prevent., 32, 623, 10.1016/S0001-4575(99)00110-4

Mura, 2002, Cannabis et conduite automobile: une valeur sanguine limite est-elle nécessaire?, Ann. de Toxicol. Anal., 14, 149

Harder, 1997, Concentration-effect relationship of delta-9-tetrahydrocannabinol and prediction of psychotropic effects after smoking marijuana, Int. Clin. Pharmacol. Ther., 35, 155

Kintz, 1996, Sweat testing in opioid users with a sweat patch, J. Anal. Toxicol., 20, 393, 10.1093/jat/20.6.393

Gaillard, 1996, Identification et dosage de la benzoylecgonine, cocaı̈ne méthylecgonine-ester, codéine, morphine et 6-monoacétylmorphine dans le sang total, Toxicorama, 8, 17

Marquet, 1996, Identification et dosage des principales drogues amphétaminiques dans le sang total par chromatographie en phase gazeuse couplée à la spectrométrie de masse, Toxicorama, 8, 23

Kintz, 1996, Identification et dosage des cannabinoı̈des dans le sang total, Toxicorama, 8, 29

J. Officiel de la République Française, 18 September 2001, p. 14802.

Selden, 1990, Marijuana, Emergency Med. Clin. North Am., 8, 527, 10.1016/S0733-8627(20)30257-1

Cochetto, 1981, Relationship between plasma delta-9-tetrahydrocannabinol and pharmacologic effects in man, Psychopharmacology, 75, 158, 10.1007/BF00432179

Arditti, 1993, Imprégnation en benzodiazépines de conducteurs impliqués dans des accidents de la circulation, Presse Med., 22, 765

Marc, 2000, Drugs of abuse in urine of young adult drivers involved in road accidents in a Paris suburb, J. Clin. Forensic Med., 7, 77, 10.1054/jcfm.2000.0366

Marquet, 1998, Prevalence of drugs of abuse in urine of drivers involved in road accidents in France: a collaborative study, J. Forensic Sci., 43, 806, 10.1520/JFS14310J